尼日利亚传染病体外诊断市场增长、规模、份额、趋势、关键参与者分析及2031年预测

  • Report Code : TIPRE00040952
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 88
立即购买

尼日利亚传染病体外诊断市场规模预计将从2024年的4104万美元增至2031年的5967万美元。预计2024年至2031年期间,该市场的复合年增长率将达到5.5%。技术进步有望在未来几年为尼日利亚传染病体外诊断市场带来新的趋势。

尼日利亚传染病体外诊断市场分析

尼日利亚传染病体外诊断 (IVD) 市场正因多个关键驱动因素和新兴机遇而不断扩张。拉沙热、艾滋病毒和疟疾等传染病的发病率不断上升,对及时准确的诊断解决方案的需求日益迫切。国家健康保险计划 (NHIS) 等政府举措进一步支持了这一需求,提高了诊断服务的可及性。技术进步,尤其是在即时检测 (POCT) 和分子诊断领域的进步,对于提供快速精准的诊断结果至关重要,这对于在资源匮乏的环境中有效管理疾病至关重要。将人工智能 (AI) 和机器学习 (ML) 融入诊断流程也彻底改变了数据分析,从而实现更精准、更个性化的疾病检测。这些发展为利益相关者提供了重要的投资机会,使其能够投资于创新的诊断技术,以满足尼日利亚民众日益增长的医疗保健需求。

尼日利亚传染病体外诊断市场概况

主要参与者正致力于提升本地生产能力、促进创新并减少对进口诊断产品的依赖。2025年5月,尼日利亚制药公司Codix Pharma Ltd委托Codix Bio Ltd在奥贡州萨加穆设立了一家体外诊断(IVD)生产工厂。该工厂是尼日利亚第一家、撒哈拉以南非洲地区第二家IVD生产工厂,预计每年将生产超过1.47亿份疟疾、艾滋病毒以及乙肝和丙肝快速诊断检测试剂盒。这一举措满足了对及时、负担得起的本地化诊断试剂盒的需求,尤其是服务匮乏的人群。此类举措将增强医疗保健独立性,改善疾病监测,并推动市场增长。

定制此报告以满足您的要求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

尼日利亚传染病体外诊断市场:

Nigeria Infectious Disease In-vitro Diagnostics Market
  • 获取此报告的顶级关键市场趋势。
    此免费样品将包括数据分析,从市场趋势到估计和预测。

尼日利亚传染病体外诊断市场驱动因素和机遇

诊断中心数量不断增加 

截至2025年5月,尼日利亚共有937家诊断中心,较2023年增长3.65%。其中,899家诊断中心(占尼日利亚所有诊断中心的95.94%)由单一业主运营,其余38家(占4.06%)隶属于大型品牌。诊断中心数量最多的三个州分别是拉各斯州(256家)、联邦首都特区(104家)和埃努古州(72家)。

随着疟疾、艾滋病毒和结核病负担的加重,对准确及时的诊断服务的需求激增。诊断中心的增加,特别是在城市和半城市地区,提高了医疗保健的可及性并减少了患者的周转时间,从而促进了 IVD 技术的采用。建立 54gene 和 Lifebank 等私人实验室以及尼日利亚疾病控制中心 (NCDC) 下属的公共举措提高了 COVID-19 和拉沙热的检测能力。这些中心依靠分子诊断、免疫测定和快速检测试剂盒。与国际伙伴的合作促进了能力建设和技术转让。诊断能力的扩展可提高准确诊断、疾病监测、支持公共卫生应对和制定医疗政策,从而促进市场增长。

政府提高公众对传染病认识的举措

尼日利亚政府通过疾病控制中心 (NCDC) 和卫生部,大力推广针对疟疾、艾滋病毒/艾滋病和结核病的公共卫生运动。这些运动强调早期发现、预防和管理,鼓励更多人寻求诊断检测。随着人们意识的增强,医疗保健提供者和诊断中心正在采用先进的体外诊断 (IVD) 技术,以满足对可靠快速检测日益增长的需求。在政府支持下开展的全国性艾滋病毒筛查项目也增加了对高效体外诊断试剂盒的需求。

与国际卫生组织的合作以及政府补贴有助于提高这些诊断工具的可及性,尤其是在农村和服务欠缺地区。这种支持性环境吸引了众多诊断公司的投资,旨在开发和推广符合当地需求的创新检测解决方案。通过创造对诊断创新的持续需求,政府主导的宣传活动有望为尼日利亚传染病的未来发展创造机会。

尼日利亚传染病报告细分分析

有助于得出传染病体外诊断市场分析的关键部分是应用、最终用户和地理位置。

  • 根据应用,尼日利亚传染病体外诊断市场细分为艾滋病毒/艾滋病、结核病、乙肝和丙肝、疟疾及其他疾病。疟疾领域在2024年占据了最大的市场份额,预计在2024年至2031年期间将实现显著的复合年增长率。
  • 按最终用户划分,市场分为医院和诊所、诊断实验室、血库和其他。2024年,医院和诊所占据了尼日利亚传染病体外诊断市场的最大份额。

尼日利亚传染病体外诊断市场份额(按地区)分析

尼日利亚传染病体外诊断市场正在稳步扩张,这主要得益于艾滋病毒/艾滋病、疟疾、结核病和肝炎等传染病的高发性。随着人口增长以及对早期精准疾病检测需求的不断增长,诊断技术、快速检测和即时诊断技术正在被广泛采用。由于医疗基础设施的改善,城市地区的体外诊断渗透率正在提高,而农村地区仍然服务不足,但拥有巨大的增长潜力。政府的医疗卫生计划、国际捐助资金以及逐步向本地化生产和公私合作模式转变,为市场提供了支撑。然而,诊断实验室数量有限、监管严格以及技术人员不足等挑战依然存在。总体而言,该行业拥有强大的投资和创新潜力,尤其是在便携式和经济实惠的诊断解决方案方面。

尼日利亚传染病体外诊断

尼日利亚传染病体外诊断市场区域洞察

Insight Partners 的分析师已详尽阐述了预测期内影响尼日利亚传染病体外诊断市场的区域趋势和因素。本节还讨论了尼日利亚传染病体外诊断市场在北美、欧洲、亚太、中东和非洲以及南美和中美的细分市场和地域分布。

Nigeria Infectious Disease In-vitro Diagnostics Market
  • 获取尼日利亚传染病体外诊断市场的区域特定数据

尼日利亚传染病体外诊断市场报告范围

报告属性细节
2024年的市场规模4104万美元
2031年的市场规模5967万美元
全球复合年增长率(2024-2031)5.5%
史料2021-2022
预测期2024-2031
涵盖的领域按应用
  • 艾滋病毒/艾滋病
  • 结核
  • 乙型肝炎和丙型肝炎
  • 疟疾
按最终用户
  • 医院和诊所
  • 诊断实验室
  • 血库
覆盖地区和国家尼日利亚
  • 尼日利亚
市场领导者和主要公司简介
  • 雅培实验室
  • F.霍夫曼-罗氏有限公司
  • 贝克顿迪金森公司
  • Sysmex公司
  • 生物梅里埃公司
  • Bio-Rad实验室公司
  • 凯杰公司
  • QuidelOrtho公司
  • 布鲁克公司

 

尼日利亚传染病体外诊断市场参与者密度:了解其对业务动态的影响

尼日利亚传染病体外诊断市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的演变、技术进步以及对产品优势的认知度的提升。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。

市场参与者密度是指特定市场或行业内企业或公司的分布情况。它表明特定市场空间内竞争对手(市场参与者)的数量相对于其规模或总市值而言。

在尼日利亚传染病体外诊断市场运营的主要公司有:

  1. 雅培实验室
  2. F.霍夫曼-罗氏有限公司
  3. 贝克顿迪金森公司
  4. Sysmex公司
  5. 生物梅里埃公司
  6. Bio-Rad实验室公司

免责声明以上列出的公司没有按照任何特定顺序排列。


Nigeria Infectious Disease In-vitro Diagnostics Market

 

  • 获取尼日利亚传染病体外诊断市场主要参与者概览

尼日利亚传染病体外诊断市场新闻及最新发展

尼日利亚传染病体外诊断市场评估通过收集一手和二手研究的定性和定量数据进行,这些数据包括重要的企业出版物、协会数据和数据库。以下列出了市场的一些关键发展:

  • 布鲁克公司在维也纳举行的欧洲传染病与传染病协会(ESCMID)全球大会上宣布扩展其传染病检测解决方案,包括扩展其BeGenius分子诊断系统的检测菜单,并改进其微生物鉴定平台。(来源:布鲁克公司,公司网站,2025年4月)
  • 体外诊断领域的全球领导者生物梅里埃宣布推出其 WATCHFIRE 分子检测解决方案。WATCHFIRE 呼吸道 (R) 检测板针对 22 种病原体*,将在 BIOFIRE FILMARRAY TORCH 仪器上运行,并集成 FIREWORKS™ 软件,以提供废水样本中病毒和细菌的实时趋势分析。(来源:生物梅里埃,公司网站,2025 年 4 月)

尼日利亚传染病体外诊断市场报告覆盖范围和交付成果

《尼日利亚传染病体外诊断市场规模和预测(2021-2031)》报告对以下领域进行了详细的市场分析:

  • 传染病体外诊断市场规模以及涵盖范围内所有主要细分市场的国家级预测
  • 传染病体外诊断市场趋势以及市场动态,例如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 传染病体外诊断市场分析涵盖主要市场趋势、国家框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及传染病体外诊断市场的最新发展
  • 详细的公司简介
  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
nigeria-infectious-disease-in-vitro-diagnostics-market-report-deliverables-img1
nigeria-infectious-disease-in-vitro-diagnostics-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What are the factors driving the Nigeria Infectious Disease In-vitro Diagnostics Market growth?

The increasing number of diagnostic centers and strategic developments by key players fuel the market growth.

Which are the leading players operating in the Nigeria Infectious Disease In-vitro Diagnostics Market?

Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, Sysmex Corp, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, QuidelOrtho Corp, Bruker Corp are key players in the market.

What are the future trends in the Nigeria Infectious Disease In-vitro Diagnostics Market?

Technological advancements are expected to emerge as a prime trend in the market in the coming years.

What would be the expected CAGR of the Nigeria Infectious Disease In-vitro Diagnostics Market?

The market is expected to register a CAGR of 5.5% during 2024–2031.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Nigeria Infectious Disease In-vitro Diagnostics Market

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • Sysmex Corp
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • QIAGEN NV
  • QuidelOrtho Corp
  • Bruker Corp
nigeria-infectious-disease-in-vitro-diagnostics-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.